Author | Hugo Ford, MD | OncLive

Author | Hugo Ford, MD

Articles

Dr. Ford on Docetaxel in Esophagogastric Cancer

March 12, 2013

Video

Hugo Ford, MD, from the Addenbrooke's Hospital in Cambridge, UK, describes which patients with metastatic esophagogastric cancer derive the greatest benefit from second-line treatment with docetaxel.

Dr. Hugo Ford on the Phase III COUGAR-02 Study

January 29, 2013

Video

Hugo Ford, MD, from the Addenbrooke's Hospital in Cambridge, UK, describes results from the phase III COUGAR-02 study that examined second-line docetaxel in patients with advanced gastroesophageal adenocarcinoma.

x